Empowering Next-Gen Bioconjugates (ADCs/XDCs): Apeloa provides high-purity linkers and comprehensive chemistry services to accelerate your ADC, targeted conjugation, and peptide drug development ...

MALVERN, Pa.--(BUSINESS WIRE)--Alliance Pharma, a global leader providing bioanalytical, DMPK, and CMC testing services in the pharmaceutical and biopharmaceutical industry, and Drug Development ...

Enhanc3D Genomics has announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug discovery. The new 3D multi-omics offerings were designed to ...

The plant-based API market is primed for growth due to heightened demand for sustainable, natural therapeutics and regulatory acceptance. Advances in extraction and purification improve reliability ...

VANCOUVER, BC / ACCESS Newswire / September 2, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:XPHYF)(FSE:4XT) is pleased to announce the receipt of the Semaglutide active ...

HUNT VALLEY, Md.--(BUSINESS WIRE)--Pharmaceutics International, Inc. (Pii), a trusted provider of pharmaceutical development and manufacturing services, today announced the launch of its pioneering ...

This report, published by Towards Healthcare, a sister firm of Precedence Research, provides an in-depth analysis of the global CDMO services market for pharma and biotech. It highlights key growth ...

Thermo Fisher Scientific says addressing the need for prefilled syringes is among potential production bottlenecks, the company is working to address. Thermo Fisher’s Accelerator™ Drug Development ...

VANCOUVER, BC / ACCESS Newswire / July 8, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a development-stage biopharmaceutical company specializing in ...

MANCHESTER, United Kingdom and HYDERABAD, India, Oct. 08, 2025 (GLOBE NEWSWIRE) -- Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), Agility Life Sciences, and Centrix Pharma Solutions today announced ...

RADNOR, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (CERT), a global leader in model-informed drug development, today announced the appointment of Adrian McKemey, Ph.D. as President of Drug ...

MSIDA, Malta, Oct. 05, 2017 (GLOBE NEWSWIRE) -- DRGT, a specialty pharmaceutical company, today announced the results of its Phase I study of DRGT18-2, a novel formulation of Sirolimus (Rapamune®), ...